个人中心 - 老虎社区

SebZz

IP属地：未知

帖子 · 47帖子 · 47
关注 · 0关注 · 0
粉丝 · 0粉丝 · 0

- SebZzSebZz
  ·2021-12-24
  Ok
  Japan health panel approves Merck's oral COVID-19 treatment
  TOKYO, Dec 24 (Reuters) - A Japanese health ministry panel on Friday recommended approval of the COV
  Japan health panel approves Merck's oral COVID-19 treatment
  907 2
  9
  分享
  举报
- SebZzSebZz
  ·2021-12-24
  Ok
  非常抱歉，此主贴已删除
  1,065 1
  3
  分享
  举报
- SebZzSebZz
  ·2021-12-06
  Nice
  Apple Stock Is an Attractive Buy, Says KeyBanc. Price Target Set at $191.
  Apple shares were rising Monday after analysts at KeyBanc Capital Markets initiated coverage on the
  Apple Stock Is an Attractive Buy, Says KeyBanc. Price Target Set at $191.
  961 评论
  2
  分享
  举报
- SebZzSebZz
  ·2021-12-03
  Nice
  Clover Stock Has Slumped. Buy the Dip?
  Clover Health stock has been struggling in the past few months. Shares have reached 80% lower since
  Clover Stock Has Slumped. Buy the Dip?
  906 评论
  1
  分享
  举报
- SebZzSebZz
  ·2021-12-02
  Nice
  Novartis Says Top Drugs Should Fuel Sales Growth Through 2026
  Novartis AG said Thursday ahead of its research-and-development day starting later today that it exp
  Novartis Says Top Drugs Should Fuel Sales Growth Through 2026
  825 评论
  3
  分享
  举报
- SebZzSebZz
  ·2021-11-30
  Evil
  Google failed to honor 'don't be evil' pledge in firing engineers - lawsuit
  A group of former Google employees sued the Alphabet Inc unit on Monday alleging that it breached th
  Google failed to honor 'don't be evil' pledge in firing engineers - lawsuit
  892 评论
  1
  分享
  举报
- SebZzSebZz
  ·2021-11-30
  Nic3
  非常抱歉，此主贴已删除
  733 评论
  3
  分享
  举报
- SebZzSebZz
  ·2021-11-29
  Nice
  非常抱歉，此主贴已删除
  857 评论
  点赞
  分享
  举报
- SebZzSebZz
  ·2021-11-29
  Nice
  Oil rebounds on speculation OPEC+ may pause output increase
  TOKYO, Nov 29 (Reuters) - Oil prices rebounded on Monday as investors looked for bargains after Frid
  Oil rebounds on speculation OPEC+ may pause output increase
  1,116 评论
  点赞
  分享
  举报
- SebZzSebZz
  ·2021-11-28
  Ok
  U.S. Black Friday shoppers tapered online splurge, as some returned to stores
  (Reuters) - U.S. shoppers spent slightly less online during Black Friday this year, with many ventur
  U.S. Black Friday shoppers tapered online splurge, as some returned to stores
  732 评论
  3
  分享
  举报
暂无关注

热议股票

关于我们·老虎社区守则·老虎社区账号管理规范·老虎社区服务协议·老虎社区隐私政策

公司名称：北京至简风宜信息技术有限公司

违法和不良信息投诉：010-5681-3562（工作时间9:30-18:30）

邮箱：service@laohu8.com

老虎社区侵权投诉指引

中国互联网举报中心·北京互联网举报中心

网络谣言曝光台·扫黄打非举报中心

网络110报警服务

© 2018-2024 老虎社区版权所有

营业执照：91110105MA01A4U55R

ICP备：京ICP备18016422号

网安备：京公网安备11010502036490

qrcode

关注我们

{"i18n":{"language":"zh_CN"},"isCurrentUser":false,"userPageInfo":{"id":"3571302905057300","uuid":"3571302905057300","gmtCreate":1608209527730,"gmtModify":1608209527730,"name":"SebZz","pinyin":"sebzz","introduction":"","introductionEn":"","signature":"","avatar":"https://static.laohu8.com/default-avatar.jpg","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":2,"headSize":8,"tweetSize":47,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-2","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"资深虎友","description":"加入老虎社区1000天","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.09.14","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":2,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":4,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":698827967,"gmtCreate":1640346251244,"gmtModify":1640346251351,"author":{"id":"3571302905057300","authorId":"3571302905057300","name":"SebZz","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3571302905057300","authorIdStr":"3571302905057300"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/698827967","repostId":"2193127176","repostType":4,"repost":{"id":"2193127176","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1640345481,"share":"https://www.laohu8.com/m/news/2193127176?lang=&edition=full","pubTime":"2021-12-24 19:31","market":"us","language":"en","title":"Japan health panel approves Merck's oral COVID-19 treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2193127176","media":"Reuters","summary":"TOKYO, Dec 24 (Reuters) - A Japanese health ministry panel on Friday recommended approval of the COV","content":"<p>TOKYO, Dec 24 (Reuters) - A Japanese health ministry panel on Friday recommended approval of the COVID-19 antiviral pill developed by Merck &amp; Co Inc , part of plans by Prime Minister Fumio Kishida to roll out new treatments by yearend as concerns rise about the Omicron variant.</p>\n<p>The panel decision sets the stage for shipments of 200,000 doses across the country from this weekend, based on preparations announced earlier by Kishida.</p>\n<p>Japan is betting heavily on oral treatments to keep serious infections and deaths at bay should a feared sixth wave of the pandemic emerge. The government agreed last month to pay Merck and its partner Ridgeback Biotherapeutics about $1.2 billion for 1.6 million courses of their drug molnupiravir.</p>\n<p>In addition, Kishida announced last week a deal to procure 2 million doses of a separate antiviral pill&nbsp;developed by Pfizer Inc. And Japan's Shionogi &amp; Co is expected to soon file for approval of its own treatment&nbsp;supplying another 1 million doses by early next year.</p>\n<p>U.S. regulators on Thursday authorized the Merck pill for certain high-risk adult patients.</p>\n<p>Countries rushed to buy Merck's molnupiravir after very promising initial results, but subsequent company data in late November indicated the drug was markedly less effective than previously thought. France cancelled its order on Wednesday.</p>\n<p>Japan this week confirmed the first known cases of Omicron infections that could not be traced back to overseas travelers. Community transmissions of the variant have now been found in the western cities of Osaka and Kyoto, and a suspected case was announced in Tokyo on Friday.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Japan health panel approves Merck's oral COVID-19 treatment</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nJapan health panel approves Merck's oral COVID-19 treatment\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-12-24 19:31</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>TOKYO, Dec 24 (Reuters) - A Japanese health ministry panel on Friday recommended approval of the COVID-19 antiviral pill developed by Merck &amp; Co Inc , part of plans by Prime Minister Fumio Kishida to roll out new treatments by yearend as concerns rise about the Omicron variant.</p>\n<p>The panel decision sets the stage for shipments of 200,000 doses across the country from this weekend, based on preparations announced earlier by Kishida.</p>\n<p>Japan is betting heavily on oral treatments to keep serious infections and deaths at bay should a feared sixth wave of the pandemic emerge. The government agreed last month to pay Merck and its partner Ridgeback Biotherapeutics about $1.2 billion for 1.6 million courses of their drug molnupiravir.</p>\n<p>In addition, Kishida announced last week a deal to procure 2 million doses of a separate antiviral pill&nbsp;developed by Pfizer Inc. And Japan's Shionogi &amp; Co is expected to soon file for approval of its own treatment&nbsp;supplying another 1 million doses by early next year.</p>\n<p>U.S. regulators on Thursday authorized the Merck pill for certain high-risk adult patients.</p>\n<p>Countries rushed to buy Merck's molnupiravir after very promising initial results, but subsequent company data in late November indicated the drug was markedly less effective than previously thought. France cancelled its order on Wednesday.</p>\n<p>Japan this week confirmed the first known cases of Omicron infections that could not be traced back to overseas travelers. Community transmissions of the variant have now been found in the western cities of Osaka and Kyoto, and a suspected case was announced in Tokyo on Friday.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4007":"制药","MRK":"默沙东","BK4559":"巴菲特持仓","BK4534":"瑞士信贷持仓","BK4550":"红杉资本持仓","BK4516":"特朗普概念","BK4533":"AQR资本管理(全球第二大对冲基金)"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2193127176","content_text":"TOKYO, Dec 24 (Reuters) - A Japanese health ministry panel on Friday recommended approval of the COVID-19 antiviral pill developed by Merck & Co Inc , part of plans by Prime Minister Fumio Kishida to roll out new treatments by yearend as concerns rise about the Omicron variant.\nThe panel decision sets the stage for shipments of 200,000 doses across the country from this weekend, based on preparations announced earlier by Kishida.\nJapan is betting heavily on oral treatments to keep serious infections and deaths at bay should a feared sixth wave of the pandemic emerge. The government agreed last month to pay Merck and its partner Ridgeback Biotherapeutics about $1.2 billion for 1.6 million courses of their drug molnupiravir.\nIn addition, Kishida announced last week a deal to procure 2 million doses of a separate antiviral pill developed by Pfizer Inc. And Japan's Shionogi & Co is expected to soon file for approval of its own treatment supplying another 1 million doses by early next year.\nU.S. regulators on Thursday authorized the Merck pill for certain high-risk adult patients.\nCountries rushed to buy Merck's molnupiravir after very promising initial results, but subsequent company data in late November indicated the drug was markedly less effective than previously thought. France cancelled its order on Wednesday.\nJapan this week confirmed the first known cases of Omicron infections that could not be traced back to overseas travelers. Community transmissions of the variant have now been found in the western cities of Osaka and Kyoto, and a suspected case was announced in Tokyo on Friday.","news_type":1},"isVote":1,"tweetType":1,"viewCount":907,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":698827045,"gmtCreate":1640346239313,"gmtModify":1640346239379,"author":{"id":"3571302905057300","authorId":"3571302905057300","name":"SebZz","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3571302905057300","authorIdStr":"3571302905057300"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/698827045","repostId":"1142015669","repostType":4,"isVote":1,"tweetType":1,"viewCount":1065,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":606052903,"gmtCreate":1638802796173,"gmtModify":1638802796260,"author":{"id":"3571302905057300","authorId":"3571302905057300","name":"SebZz","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3571302905057300","authorIdStr":"3571302905057300"},"themes":[],"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/606052903","repostId":"1107494736","repostType":4,"repost":{"id":"1107494736","pubTimestamp":1638799191,"share":"https://www.laohu8.com/m/news/1107494736?lang=&edition=full","pubTime":"2021-12-06 21:59","market":"us","language":"en","title":"Apple Stock Is an Attractive Buy, Says KeyBanc. Price Target Set at $191.","url":"https://stock-news.laohu8.com/highlight/detail?id=1107494736","media":"Barrons","summary":"Apple shares were rising Monday after analysts at KeyBanc Capital Markets initiated coverage on the ","content":"<p>Apple&nbsp;shares were rising Monday after analysts at KeyBanc Capital Markets initiated coverage on the stock with a bullish outlook, citing growth in the tech giant’s services segment.</p>\n<p>Analyst Brandon Nispel rated the stock Overweight with a $191 price target. The target presents an 18% increase from Apple’s (ticker: AAPL) $161.84 closing price on Friday. The stock was up 1.2% to $163.73 in premarket trading Monday.</p>\n<p>Of the 42 analysts covering the stock surveyed by FactSet, 32 have it at a Buy or Overweight rating, nine rated it at Hold, and one rated it Underweight.</p>\n<p>“While AAPL is expensive by historical valuations, we find AAPL attractive relative to other mega-caps,” Nispel wrote on Monday.</p>\n<p>The analyst outlined three main reasons for his bullish take. Nispel doesn’t believe iPhone unit sales have peaked, with the 5G upgrade cycle potentially pushing Apple past its current peak; he believes the company has managed to increase its product breadth to reduce reliability on iPhone sales; and he foresees services to grow at rates multiple times faster than user growth.</p>\n<p>The analyst forecasts Apple to have 1.09 billion active iPhones and 1.8 billion active installed devices by the end of the first quarter of the 2022 fiscal year. This presents a 7% and 8% year-over-year increase, respectively.</p>\n<p>“This shows a healthy growing user base where Apple iPhone market share is low relative to key geographies outside the United States,” Nispel wrote. “As the installed base grows, a larger base can support more sales on lower upgrade rates.”</p>\n<p>Apple’s international segment is likely to grow faster in the coming years as other countries adapt to 5G, prompting a wave of upgrades to compatible hardware, Nispel wrote. He estimates every 1% increase in 5G upgrade rates could drive an incremental 11 million iPhone unit sales.</p>\n<p>As hardware adoption grows, so does Apple’s services business. The segment, which includes services such as Apple TV+, Music, News+, AppleCare, Advertising, and Cloud, has grown 27% in the 2021 fiscal year. Over time, it could become a key profitability driver, growing to more than $100 billion by 2024, Nispel said.</p>\n<p>Nispel recognized that Apple’s App Store legal battles were concerning, but were “likely more a bend, not break outcome.” The company has had to make modest changes to its App Store guidance in response to court rulings and regulatory changes, including lowering its commission for some developers. It will likely make more concessions over time, such as allowing developers to provide third-party payment options, Nispel said.</p>\n<p>“We expect regulation to take time to implement, and believe Apple’s competitive advantage is unlikely to be substantially harmed,” he added.</p>","source":"lsy1601382232898","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Apple Stock Is an Attractive Buy, Says KeyBanc. Price Target Set at $191.</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nApple Stock Is an Attractive Buy, Says KeyBanc. Price Target Set at $191.\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-06 21:59 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.barrons.com/articles/apple-aapl-stock-attractive-buy-51638798446?mod=hp_LATEST><strong>Barrons</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Apple shares were rising Monday after analysts at KeyBanc Capital Markets initiated coverage on the stock with a bullish outlook, citing growth in the tech giant’s services segment.\nAnalyst Brandon ...</p>\n\n<a href=\"https://www.barrons.com/articles/apple-aapl-stock-attractive-buy-51638798446?mod=hp_LATEST\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.barrons.com/articles/apple-aapl-stock-attractive-buy-51638798446?mod=hp_LATEST","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1107494736","content_text":"Apple shares were rising Monday after analysts at KeyBanc Capital Markets initiated coverage on the stock with a bullish outlook, citing growth in the tech giant’s services segment.\nAnalyst Brandon Nispel rated the stock Overweight with a $191 price target. The target presents an 18% increase from Apple’s (ticker: AAPL) $161.84 closing price on Friday. The stock was up 1.2% to $163.73 in premarket trading Monday.\nOf the 42 analysts covering the stock surveyed by FactSet, 32 have it at a Buy or Overweight rating, nine rated it at Hold, and one rated it Underweight.\n“While AAPL is expensive by historical valuations, we find AAPL attractive relative to other mega-caps,” Nispel wrote on Monday.\nThe analyst outlined three main reasons for his bullish take. Nispel doesn’t believe iPhone unit sales have peaked, with the 5G upgrade cycle potentially pushing Apple past its current peak; he believes the company has managed to increase its product breadth to reduce reliability on iPhone sales; and he foresees services to grow at rates multiple times faster than user growth.\nThe analyst forecasts Apple to have 1.09 billion active iPhones and 1.8 billion active installed devices by the end of the first quarter of the 2022 fiscal year. This presents a 7% and 8% year-over-year increase, respectively.\n“This shows a healthy growing user base where Apple iPhone market share is low relative to key geographies outside the United States,” Nispel wrote. “As the installed base grows, a larger base can support more sales on lower upgrade rates.”\nApple’s international segment is likely to grow faster in the coming years as other countries adapt to 5G, prompting a wave of upgrades to compatible hardware, Nispel wrote. He estimates every 1% increase in 5G upgrade rates could drive an incremental 11 million iPhone unit sales.\nAs hardware adoption grows, so does Apple’s services business. The segment, which includes services such as Apple TV+, Music, News+, AppleCare, Advertising, and Cloud, has grown 27% in the 2021 fiscal year. Over time, it could become a key profitability driver, growing to more than $100 billion by 2024, Nispel said.\nNispel recognized that Apple’s App Store legal battles were concerning, but were “likely more a bend, not break outcome.” The company has had to make modest changes to its App Store guidance in response to court rulings and regulatory changes, including lowering its commission for some developers. It will likely make more concessions over time, such as allowing developers to provide third-party payment options, Nispel said.\n“We expect regulation to take time to implement, and believe Apple’s competitive advantage is unlikely to be substantially harmed,” he added.","news_type":1},"isVote":1,"tweetType":1,"viewCount":961,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":601607958,"gmtCreate":1638517719122,"gmtModify":1638517719122,"author":{"id":"3571302905057300","authorId":"3571302905057300","name":"SebZz","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3571302905057300","authorIdStr":"3571302905057300"},"themes":[],"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/601607958","repostId":"1138290638","repostType":4,"repost":{"id":"1138290638","pubTimestamp":1638515006,"share":"https://www.laohu8.com/m/news/1138290638?lang=&edition=full","pubTime":"2021-12-03 15:03","market":"us","language":"en","title":"Clover Stock Has Slumped. Buy the Dip?","url":"https://stock-news.laohu8.com/highlight/detail?id=1138290638","media":"TheStreet","summary":"Clover Health stock has been struggling in the past few months. Shares have reached 80% lower since ","content":"<p>Clover Health stock&nbsp;has been struggling in the past few months. Shares have reached 80% lower since the early June peak as CLOV’s “meme” momentum faded.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/528f59c934a300195181e1a4f4dda4a0\" tg-width=\"1240\" tg-height=\"698\" width=\"100%\" height=\"auto\"><span>Figure 1: Clover Health logo.</span></p>\n<p>Now, CLOV has hit bottom as shares trade at all-time lows of less than $5. Below, we have listed a few questions that could help determine if now is the time to invest in the stock.</p>\n<p><b>The success of Clover Assistant</b></p>\n<p>AI software platform Clover Assistant is the key differentiator in Clover’s unique model, and it has nearly 100,000 lives under management. The platform was designed to help physicians improve their services and attract new members.</p>\n<p>Clover’s business model is heavily dependent on the platform, but experts are skeptical as to whether it can deliver what it promises: ease of use for doctors and money saving opportunities for patients. Clover Assistant has grown 223% YOY and&nbsp;approximately&nbsp;2,900 health care professionals used Clover Assistant in Q3, up 45% YOY.</p>\n<p><b>Are bears right?</b></p>\n<p>Known as the “king of SPACs,” Clover saw its stock price plummet earlier this year. The likely culprit: research firm Hindenburgshortedthe stock, claiming that the company was the target of an investigation for dubious sales practices.</p>\n<p>After Hindenburg's bet, CLOV share price plunged 50% year-to-date by the end of May. At that point, the stock caught the attention of Wall Street Bets’ “apes” community and became a target of meme mania. Since early June, stocks spiked 190% but then fell around 80% to all-time lows.</p>\n<p>Venture capitalist Chamath Palihapitiya, who helped Clover go public through SPAC,defended&nbsp;the company from the allegations. But at that point, it may have been too late: skepticism towards CLOV had spread wide and the stock became a short seller favorite.</p>\n<p>Currently, short interest is a bit on the hot side: 12% of the float is currently shorted,according&nbsp;to Yahoo Finance. We like to think that anything above 10% is a bearish indicator and a potential short squeeze candidate.</p>\n<p><b>CLOV’s path to profitability</b></p>\n<p>Clover Health’s “meme” momentum driven by sheer buzz and enthusiasm seems to have lost steam as the main discussion boards “cooled down” on the name. Now, CLOV shares could trade more in line with business fundamentals.</p>\n<p>In that regard, the company has been a strong revenue generator in a&nbsp;market&nbsp;with multi-billion dollar potential: Medicare Advantage. In Q3, Clover&nbsp;generated&nbsp;$472 million in revenues, up an astounding 153% YOY. However, the company is still far from being profitable. Full year 2021 adjusted EBITDA is&nbsp;expected&nbsp;to sit around negative $250 million and $230 million.</p>\n<p>One key question is how long it may take for Clover to reach profits with the current business model. Another is whether the company will be able to expand outside its current territory. The answers to these questions will likely drive the stock’s performance in the foreseeable future.</p>\n<p>Lastly, according to Wall Street experts, CLOV stock is&nbsp;undervalued&nbsp;at current levels. Despite the consensus rating on the stock leaning heavily towards cautious, average price target sits at $8.67, suggesting 76% upside potential from here.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Clover Stock Has Slumped. Buy the Dip?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nClover Stock Has Slumped. Buy the Dip?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-03 15:03 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.thestreet.com/memestocks/clov/clov-stock-has-hit-rock-bottom-time-to-buy><strong>TheStreet</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Clover Health stock has been struggling in the past few months. Shares have reached 80% lower since the early June peak as CLOV’s “meme” momentum faded.\nFigure 1: Clover Health logo.\nNow, CLOV has hit...</p>\n\n<a href=\"https://www.thestreet.com/memestocks/clov/clov-stock-has-hit-rock-bottom-time-to-buy\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.thestreet.com/memestocks/clov/clov-stock-has-hit-rock-bottom-time-to-buy","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1138290638","content_text":"Clover Health stock has been struggling in the past few months. Shares have reached 80% lower since the early June peak as CLOV’s “meme” momentum faded.\nFigure 1: Clover Health logo.\nNow, CLOV has hit bottom as shares trade at all-time lows of less than $5. Below, we have listed a few questions that could help determine if now is the time to invest in the stock.\nThe success of Clover Assistant\nAI software platform Clover Assistant is the key differentiator in Clover’s unique model, and it has nearly 100,000 lives under management. The platform was designed to help physicians improve their services and attract new members.\nClover’s business model is heavily dependent on the platform, but experts are skeptical as to whether it can deliver what it promises: ease of use for doctors and money saving opportunities for patients. Clover Assistant has grown 223% YOY and approximately 2,900 health care professionals used Clover Assistant in Q3, up 45% YOY.\nAre bears right?\nKnown as the “king of SPACs,” Clover saw its stock price plummet earlier this year. The likely culprit: research firm Hindenburgshortedthe stock, claiming that the company was the target of an investigation for dubious sales practices.\nAfter Hindenburg's bet, CLOV share price plunged 50% year-to-date by the end of May. At that point, the stock caught the attention of Wall Street Bets’ “apes” community and became a target of meme mania. Since early June, stocks spiked 190% but then fell around 80% to all-time lows.\nVenture capitalist Chamath Palihapitiya, who helped Clover go public through SPAC,defended the company from the allegations. But at that point, it may have been too late: skepticism towards CLOV had spread wide and the stock became a short seller favorite.\nCurrently, short interest is a bit on the hot side: 12% of the float is currently shorted,according to Yahoo Finance. We like to think that anything above 10% is a bearish indicator and a potential short squeeze candidate.\nCLOV’s path to profitability\nClover Health’s “meme” momentum driven by sheer buzz and enthusiasm seems to have lost steam as the main discussion boards “cooled down” on the name. Now, CLOV shares could trade more in line with business fundamentals.\nIn that regard, the company has been a strong revenue generator in a market with multi-billion dollar potential: Medicare Advantage. In Q3, Clover generated $472 million in revenues, up an astounding 153% YOY. However, the company is still far from being profitable. Full year 2021 adjusted EBITDA is expected to sit around negative $250 million and $230 million.\nOne key question is how long it may take for Clover to reach profits with the current business model. Another is whether the company will be able to expand outside its current territory. The answers to these questions will likely drive the stock’s performance in the foreseeable future.\nLastly, according to Wall Street experts, CLOV stock is undervalued at current levels. Despite the consensus rating on the stock leaning heavily towards cautious, average price target sits at $8.67, suggesting 76% upside potential from here.","news_type":1},"isVote":1,"tweetType":1,"viewCount":906,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":603567349,"gmtCreate":1638429661733,"gmtModify":1638429661852,"author":{"id":"3571302905057300","authorId":"3571302905057300","name":"SebZz","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3571302905057300","authorIdStr":"3571302905057300"},"themes":[],"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/603567349","repostId":"1159695915","repostType":4,"repost":{"id":"1159695915","pubTimestamp":1638429346,"share":"https://www.laohu8.com/m/news/1159695915?lang=&edition=full","pubTime":"2021-12-02 15:15","market":"us","language":"en","title":"Novartis Says Top Drugs Should Fuel Sales Growth Through 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=1159695915","media":"Marketwatch","summary":"Novartis AG said Thursday ahead of its research-and-development day starting later today that it exp","content":"<p>Novartis AG said Thursday ahead of its research-and-development day starting later today that it expects sales to keep growing in the mid-term mainly thanks to its main in-market growth drivers, while several new assets could be approved by 2026.</p>\n<p>The Swiss pharma giant said that sales should continue to rise at a compound annual growth rate of at least 4% through 2026, driven by multi-billion dollar sales from its medicines Cosentyx, Entresto, Kesimpta, Zolgensma, Kisqali and Leqvio.</p>\n<p>\"Up to 20 new assets with significant sales potential could be approved by 2026, which will fuel the next phase of growth and address major unmet needs,\" Novartis's Chief Executive Vas Narasimhan said.</p>\n<p>Novartis also said that Cosentyx, its largest drug by sales, met primary efficacy endpoints in two phase 3 studies called Sunrise and Sunshine in which patients are treated for moderate to severe hidradenitis suppurativa--a chronic skin disease.</p>","source":"market_watch","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Novartis Says Top Drugs Should Fuel Sales Growth Through 2026</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNovartis Says Top Drugs Should Fuel Sales Growth Through 2026\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-02 15:15 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.marketwatch.com/story/novartis-says-top-drugs-should-fuel-sales-growth-through-2026-271638427973?mod=newsviewer_click><strong>Marketwatch</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Novartis AG said Thursday ahead of its research-and-development day starting later today that it expects sales to keep growing in the mid-term mainly thanks to its main in-market growth drivers, while...</p>\n\n<a href=\"https://www.marketwatch.com/story/novartis-says-top-drugs-should-fuel-sales-growth-through-2026-271638427973?mod=newsviewer_click\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.marketwatch.com/story/novartis-says-top-drugs-should-fuel-sales-growth-through-2026-271638427973?mod=newsviewer_click","is_english":true,"share_image_url":"https://static.laohu8.com/599a65733b8245fcf7868668ef9ad712","article_id":"1159695915","content_text":"Novartis AG said Thursday ahead of its research-and-development day starting later today that it expects sales to keep growing in the mid-term mainly thanks to its main in-market growth drivers, while several new assets could be approved by 2026.\nThe Swiss pharma giant said that sales should continue to rise at a compound annual growth rate of at least 4% through 2026, driven by multi-billion dollar sales from its medicines Cosentyx, Entresto, Kesimpta, Zolgensma, Kisqali and Leqvio.\n\"Up to 20 new assets with significant sales potential could be approved by 2026, which will fuel the next phase of growth and address major unmet needs,\" Novartis's Chief Executive Vas Narasimhan said.\nNovartis also said that Cosentyx, its largest drug by sales, met primary efficacy endpoints in two phase 3 studies called Sunrise and Sunshine in which patients are treated for moderate to severe hidradenitis suppurativa--a chronic skin disease.","news_type":1},"isVote":1,"tweetType":1,"viewCount":825,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":609958605,"gmtCreate":1638233759561,"gmtModify":1638233759645,"author":{"id":"3571302905057300","authorId":"3571302905057300","name":"SebZz","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3571302905057300","authorIdStr":"3571302905057300"},"themes":[],"htmlText":"Evil","listText":"Evil","text":"Evil","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/609958605","repostId":"2187309641","repostType":4,"repost":{"id":"2187309641","pubTimestamp":1638232200,"share":"https://www.laohu8.com/m/news/2187309641?lang=&edition=full","pubTime":"2021-11-30 08:30","market":"us","language":"en","title":"Google failed to honor 'don't be evil' pledge in firing engineers - lawsuit","url":"https://stock-news.laohu8.com/highlight/detail?id=2187309641","media":"StreetInsider","summary":"A group of former Google employees sued the Alphabet Inc unit on Monday alleging that it breached th","content":"<p>A group of former Google employees sued the Alphabet Inc unit on Monday alleging that it breached their employment contracts by not honoring its famous motto \"don't be evil.\"</p>\n<p>In the lawsuit filed in California state court in Santa Clara county, former Google employees Rebecca Rivers, Sophie Waldman and Paul Duke alleged that they were fired two years ago for fulfilling their contractual obligation to speak up if they saw Google violating its \"don't be evil\" pledge.</p>\n<p>Google did not immediately respond to a request for comment. The company has said before that the employees violated data security policies.</p>\n<p>Their firings also have led to an ongoing National Labor Relations Board trial over whether the company engaged in unfair practices to stem growing worker organizing. Rank-and-file engineers and others working at tech companies in recent years have sought greater say over policies and projects. Management has pushed back, seeking to maintain control.</p>\n<p>The three former Google software engineers had raised concerns at town halls and other forums inside Google about the company potentially selling cloud technology to U.S. immigration authorities, which at the time were engaging in detention tactics considered inhumane by rights activists, including separating migrant children from their families.</p>\n<p>The workers considered the potential immigration work \"evil\" under Google's policies, which call for \"acting honorably and treating each other with respect\" and engaging in \"the highest possible standards of ethical business conduct,\" according to the lawsuit. The company's code of conduct says workers who think the company may be falling short of its commitment should not stay silent, the lawsuit said.</p>\n<p>The workers are seeking an unspecified amount of damages.</p>\n<p>Google has promoted \"don't be evil\" as a core value for over 20 years, including when it went public in 2004.</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Google failed to honor 'don't be evil' pledge in firing engineers - lawsuit</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGoogle failed to honor 'don't be evil' pledge in firing engineers - lawsuit\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-30 08:30 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=19284056><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>A group of former Google employees sued the Alphabet Inc unit on Monday alleging that it breached their employment contracts by not honoring its famous motto \"don't be evil.\"\nIn the lawsuit filed in ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=19284056\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.streetinsider.com/dr/news.php?id=19284056","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2187309641","content_text":"A group of former Google employees sued the Alphabet Inc unit on Monday alleging that it breached their employment contracts by not honoring its famous motto \"don't be evil.\"\nIn the lawsuit filed in California state court in Santa Clara county, former Google employees Rebecca Rivers, Sophie Waldman and Paul Duke alleged that they were fired two years ago for fulfilling their contractual obligation to speak up if they saw Google violating its \"don't be evil\" pledge.\nGoogle did not immediately respond to a request for comment. The company has said before that the employees violated data security policies.\nTheir firings also have led to an ongoing National Labor Relations Board trial over whether the company engaged in unfair practices to stem growing worker organizing. Rank-and-file engineers and others working at tech companies in recent years have sought greater say over policies and projects. Management has pushed back, seeking to maintain control.\nThe three former Google software engineers had raised concerns at town halls and other forums inside Google about the company potentially selling cloud technology to U.S. immigration authorities, which at the time were engaging in detention tactics considered inhumane by rights activists, including separating migrant children from their families.\nThe workers considered the potential immigration work \"evil\" under Google's policies, which call for \"acting honorably and treating each other with respect\" and engaging in \"the highest possible standards of ethical business conduct,\" according to the lawsuit. The company's code of conduct says workers who think the company may be falling short of its commitment should not stay silent, the lawsuit said.\nThe workers are seeking an unspecified amount of damages.\nGoogle has promoted \"don't be evil\" as a core value for over 20 years, including when it went public in 2004.","news_type":1},"isVote":1,"tweetType":1,"viewCount":892,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":609951321,"gmtCreate":1638233680704,"gmtModify":1638233688949,"author":{"id":"3571302905057300","authorId":"3571302905057300","name":"SebZz","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3571302905057300","authorIdStr":"3571302905057300"},"themes":[],"htmlText":"Nic3","listText":"Nic3","text":"Nic3","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/609951321","repostId":"1122315710","repostType":2,"isVote":1,"tweetType":1,"viewCount":733,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":600248704,"gmtCreate":1638164444630,"gmtModify":1638164444630,"author":{"id":"3571302905057300","authorId":"3571302905057300","name":"SebZz","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3571302905057300","authorIdStr":"3571302905057300"},"themes":[],"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/600248704","repostId":"1129316714","repostType":4,"isVote":1,"tweetType":1,"viewCount":857,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":600248241,"gmtCreate":1638164393395,"gmtModify":1638164393395,"author":{"id":"3571302905057300","authorId":"3571302905057300","name":"SebZz","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3571302905057300","authorIdStr":"3571302905057300"},"themes":[],"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/600248241","repostId":"2187327727","repostType":4,"repost":{"id":"2187327727","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1638161015,"share":"https://www.laohu8.com/m/news/2187327727?lang=&edition=full","pubTime":"2021-11-29 12:43","market":"fut","language":"en","title":"Oil rebounds on speculation OPEC+ may pause output increase","url":"https://stock-news.laohu8.com/highlight/detail?id=2187327727","media":"Reuters","summary":"TOKYO, Nov 29 (Reuters) - Oil prices rebounded on Monday as investors looked for bargains after Frid","content":"<p>TOKYO, Nov 29 (Reuters) - Oil prices rebounded on Monday as investors looked for bargains after Friday's slump and on speculation that OPEC+ may pause an output increase in response to the spread of Omicron, but the mood remained cautious with little known about the new variant.</p>\n<p>Brent crude futures&nbsp;climbed $3.11, or 4.3%, to $75.83 a barrel by 0355 GMT, after falling $9.50 on Friday.</p>\n<p>U.S. West Texas Intermediate <a href=\"https://laohu8.com/S/WTI\">$(WTI)$</a> crude&nbsp;was up $3.47, or 5.1%, at $71.62 a barrel, having tumbled $10.24 in the previous session.</p>\n<p>Oil prices plunged more than 10% on Friday - their biggest <a href=\"https://laohu8.com/S/AONE.U\">one</a>-day drop since April 2020 -- as the new variant spooked investors across financial markets.</p>\n<p>There are worries the new variant could derail the global economic recovery, potentially hurting oil demand, while it has also added to concerns that a supply surplus could swell in the first quarter.</p>\n<p>\"We saw some correction as the Friday's plunge in oil prices has been overdone,\" said Tatsufumi Okoshi, senior economist at Nomura Securities.</p>\n<p>\"If the market falls further, OPEC+ may pause the planned increase of crude production to support prices,\" he said.</p>\n<p>The Omicron variant spread around the world on Sunday, with new cases found in the Netherlands, Denmark and Australia even as more countries imposed travel restrictions.</p>\n<p>The World Health Organization (WHO) said it was not yet clear whether Omicron, first detected in southern Africa, is more transmissible or dangerous than other variants.</p>\n<p>The top U.S. infectious disease official, Dr. Anthony Fauci, told President Joe Biden on Sunday it will take about two weeks to have definitive information on the Omicron.</p>\n<p>The Organization of the Petroleum Exporting Countries and its allies (OPEC+) have postponed technical meetings to later this week, giving themselves more time to assess the impact of the Omicron on oil demand and prices, according to OPEC+ sources and documents.</p>\n<p>OPEC's joint ministerial monitoring committee was delayed from Tuesday to Thursday. OPEC+ will also meet on Thursday, when a policy decision will likely be announced on whether to adjust its plan to increase output by 400,000 barrels per day in January and beyond.</p>\n<p>Some analysts have suggested the group could pause the increases after the release of stocks by oil consuming countries and possible repercussions for demand from new lockdowns to contain the new variant.</p>\n<p>\"All eyes will be on how the Omicron will affect global economy and fuel demand, OPEC+ action and Iran nuclear talks this week,\" said Hiroyuki Kikukawa, general manager of research at Nissan Securities.</p>\n<p>Talks on reviving the 2015 Iran nuclear deal are to resume in Vienna on Monday, with Iran's atomic advances raising doubt as to whether a breakthrough can be made to bring Tehran and the United States back into full compliance with the accord.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Oil rebounds on speculation OPEC+ may pause output increase</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOil rebounds on speculation OPEC+ may pause output increase\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-11-29 12:43</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>TOKYO, Nov 29 (Reuters) - Oil prices rebounded on Monday as investors looked for bargains after Friday's slump and on speculation that OPEC+ may pause an output increase in response to the spread of Omicron, but the mood remained cautious with little known about the new variant.</p>\n<p>Brent crude futures&nbsp;climbed $3.11, or 4.3%, to $75.83 a barrel by 0355 GMT, after falling $9.50 on Friday.</p>\n<p>U.S. West Texas Intermediate <a href=\"https://laohu8.com/S/WTI\">$(WTI)$</a> crude&nbsp;was up $3.47, or 5.1%, at $71.62 a barrel, having tumbled $10.24 in the previous session.</p>\n<p>Oil prices plunged more than 10% on Friday - their biggest <a href=\"https://laohu8.com/S/AONE.U\">one</a>-day drop since April 2020 -- as the new variant spooked investors across financial markets.</p>\n<p>There are worries the new variant could derail the global economic recovery, potentially hurting oil demand, while it has also added to concerns that a supply surplus could swell in the first quarter.</p>\n<p>\"We saw some correction as the Friday's plunge in oil prices has been overdone,\" said Tatsufumi Okoshi, senior economist at Nomura Securities.</p>\n<p>\"If the market falls further, OPEC+ may pause the planned increase of crude production to support prices,\" he said.</p>\n<p>The Omicron variant spread around the world on Sunday, with new cases found in the Netherlands, Denmark and Australia even as more countries imposed travel restrictions.</p>\n<p>The World Health Organization (WHO) said it was not yet clear whether Omicron, first detected in southern Africa, is more transmissible or dangerous than other variants.</p>\n<p>The top U.S. infectious disease official, Dr. Anthony Fauci, told President Joe Biden on Sunday it will take about two weeks to have definitive information on the Omicron.</p>\n<p>The Organization of the Petroleum Exporting Countries and its allies (OPEC+) have postponed technical meetings to later this week, giving themselves more time to assess the impact of the Omicron on oil demand and prices, according to OPEC+ sources and documents.</p>\n<p>OPEC's joint ministerial monitoring committee was delayed from Tuesday to Thursday. OPEC+ will also meet on Thursday, when a policy decision will likely be announced on whether to adjust its plan to increase output by 400,000 barrels per day in January and beyond.</p>\n<p>Some analysts have suggested the group could pause the increases after the release of stocks by oil consuming countries and possible repercussions for demand from new lockdowns to contain the new variant.</p>\n<p>\"All eyes will be on how the Omicron will affect global economy and fuel demand, OPEC+ action and Iran nuclear talks this week,\" said Hiroyuki Kikukawa, general manager of research at Nissan Securities.</p>\n<p>Talks on reviving the 2015 Iran nuclear deal are to resume in Vienna on Monday, with Iran's atomic advances raising doubt as to whether a breakthrough can be made to bring Tehran and the United States back into full compliance with the accord.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"USO":"美国原油ETF","SCO":"二倍做空彭博原油指数ETF","DWT":"三倍做空原油ETN","DDG":"ProShares做空石油与天然气ETF","BK4213":"石油与天然气的勘探与生产","UCO":"二倍做多彭博原油ETF","WTI":"W&T海底钻探","DUG":"二倍做空石油与天然气ETF(ProShares)"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2187327727","content_text":"TOKYO, Nov 29 (Reuters) - Oil prices rebounded on Monday as investors looked for bargains after Friday's slump and on speculation that OPEC+ may pause an output increase in response to the spread of Omicron, but the mood remained cautious with little known about the new variant.\nBrent crude futures climbed $3.11, or 4.3%, to $75.83 a barrel by 0355 GMT, after falling $9.50 on Friday.\nU.S. West Texas Intermediate $(WTI)$ crude was up $3.47, or 5.1%, at $71.62 a barrel, having tumbled $10.24 in the previous session.\nOil prices plunged more than 10% on Friday - their biggest one-day drop since April 2020 -- as the new variant spooked investors across financial markets.\nThere are worries the new variant could derail the global economic recovery, potentially hurting oil demand, while it has also added to concerns that a supply surplus could swell in the first quarter.\n\"We saw some correction as the Friday's plunge in oil prices has been overdone,\" said Tatsufumi Okoshi, senior economist at Nomura Securities.\n\"If the market falls further, OPEC+ may pause the planned increase of crude production to support prices,\" he said.\nThe Omicron variant spread around the world on Sunday, with new cases found in the Netherlands, Denmark and Australia even as more countries imposed travel restrictions.\nThe World Health Organization (WHO) said it was not yet clear whether Omicron, first detected in southern Africa, is more transmissible or dangerous than other variants.\nThe top U.S. infectious disease official, Dr. Anthony Fauci, told President Joe Biden on Sunday it will take about two weeks to have definitive information on the Omicron.\nThe Organization of the Petroleum Exporting Countries and its allies (OPEC+) have postponed technical meetings to later this week, giving themselves more time to assess the impact of the Omicron on oil demand and prices, according to OPEC+ sources and documents.\nOPEC's joint ministerial monitoring committee was delayed from Tuesday to Thursday. OPEC+ will also meet on Thursday, when a policy decision will likely be announced on whether to adjust its plan to increase output by 400,000 barrels per day in January and beyond.\nSome analysts have suggested the group could pause the increases after the release of stocks by oil consuming countries and possible repercussions for demand from new lockdowns to contain the new variant.\n\"All eyes will be on how the Omicron will affect global economy and fuel demand, OPEC+ action and Iran nuclear talks this week,\" said Hiroyuki Kikukawa, general manager of research at Nissan Securities.\nTalks on reviving the 2015 Iran nuclear deal are to resume in Vienna on Monday, with Iran's atomic advances raising doubt as to whether a breakthrough can be made to bring Tehran and the United States back into full compliance with the accord.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1116,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":600335037,"gmtCreate":1638065477252,"gmtModify":1638065477252,"author":{"id":"3571302905057300","authorId":"3571302905057300","name":"SebZz","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3571302905057300","authorIdStr":"3571302905057300"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/600335037","repostId":"2186287173","repostType":4,"repost":{"id":"2186287173","pubTimestamp":1638057946,"share":"https://www.laohu8.com/m/news/2186287173?lang=&edition=full","pubTime":"2021-11-28 08:05","market":"us","language":"en","title":"U.S. Black Friday shoppers tapered online splurge, as some returned to stores","url":"https://stock-news.laohu8.com/highlight/detail?id=2186287173","media":"StreetInsider","summary":"(Reuters) - U.S. shoppers spent slightly less online during Black Friday this year, with many ventur","content":"<p>(Reuters) - U.S. shoppers spent slightly less online during Black Friday this year, with many venturing back to physical stores despite coronavirus fears, tight supplies, and retailers' efforts to encourage earlier holiday purchases.</p>\n<p>For the first time ever, spending online during Black Friday - traditionally <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the biggest shopping days of the year - fell, reversing the growth of recent years, according to data from <a href=\"https://laohu8.com/S/ADBE\">Adobe</a> Analytics, a wing of Adobe's business that specializes in data insights and tracks transactions at 80 of the top 100 U.S. retailers.</p>\n<p>Retailers lured shoppers to make holiday purchases online as early as September this year, because the supply-chain logjam has prevented them from quickly replenishing year-end merchandise. Shoppers' total outlay online during Black Friday was roughly $8.9 billion, less than the $9 billion in 2020, Adobe said. Spending online during Thanksgiving Day was flat at $5.1 billion, Adobe said.</p>\n<p>Many retailers closed physical stores on Thanksgiving this year, as they did in 2020, amid a labor shortage and the coronavirus pandemic. Stores reopened the day after Thanksgiving, and shopper visits increased by 47.5% compared to 2020, but fell by 28.3% when compared to 2019, the last pre-pandemic year, according to data from Sensormatic Solutions.</p>\n<p>Supply-chain challenges and shipping delays may have prompted shoppers to visit stores in order to increase the chances of securing gifts in time for Christmas. More are making purchases online that they can pick up in-store, which keeps shipping costs down.</p>\n<p>Macy’s, Walmart, Target and Kohl's, for example, gave shoppers the flexibility to shop online, in stores or through hybrid methods, walked away as winners on Black Friday, said Louis Navellier, chairman of investor Navellier &amp; Associates.</p>\n<p>Of those purchasing online, slightly more used their smartphones. Canadian e-commerce company Shopify said the number of shoppers on its platform who used smartphones to make purchases increased this year to 72% from 67% last year.</p>\n<p>Retailers' moves to encourage buying holiday gifts earlier could also lessen the importance of Cyber Monday, the first Monday after Thanksgiving.</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>U.S. Black Friday shoppers tapered online splurge, as some returned to stores</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nU.S. Black Friday shoppers tapered online splurge, as some returned to stores\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-28 08:05 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=19277851><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>(Reuters) - U.S. shoppers spent slightly less online during Black Friday this year, with many venturing back to physical stores despite coronavirus fears, tight supplies, and retailers' efforts to ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=19277851\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TGT":"塔吉特","WMT":"沃尔玛","M":"梅西百货","KSS":"柯尔百货"},"source_url":"https://www.streetinsider.com/dr/news.php?id=19277851","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2186287173","content_text":"(Reuters) - U.S. shoppers spent slightly less online during Black Friday this year, with many venturing back to physical stores despite coronavirus fears, tight supplies, and retailers' efforts to encourage earlier holiday purchases.\nFor the first time ever, spending online during Black Friday - traditionally one of the biggest shopping days of the year - fell, reversing the growth of recent years, according to data from Adobe Analytics, a wing of Adobe's business that specializes in data insights and tracks transactions at 80 of the top 100 U.S. retailers.\nRetailers lured shoppers to make holiday purchases online as early as September this year, because the supply-chain logjam has prevented them from quickly replenishing year-end merchandise. Shoppers' total outlay online during Black Friday was roughly $8.9 billion, less than the $9 billion in 2020, Adobe said. Spending online during Thanksgiving Day was flat at $5.1 billion, Adobe said.\nMany retailers closed physical stores on Thanksgiving this year, as they did in 2020, amid a labor shortage and the coronavirus pandemic. Stores reopened the day after Thanksgiving, and shopper visits increased by 47.5% compared to 2020, but fell by 28.3% when compared to 2019, the last pre-pandemic year, according to data from Sensormatic Solutions.\nSupply-chain challenges and shipping delays may have prompted shoppers to visit stores in order to increase the chances of securing gifts in time for Christmas. More are making purchases online that they can pick up in-store, which keeps shipping costs down.\nMacy’s, Walmart, Target and Kohl's, for example, gave shoppers the flexibility to shop online, in stores or through hybrid methods, walked away as winners on Black Friday, said Louis Navellier, chairman of investor Navellier & Associates.\nOf those purchasing online, slightly more used their smartphones. Canadian e-commerce company Shopify said the number of shoppers on its platform who used smartphones to make purchases increased this year to 72% from 67% last year.\nRetailers' moves to encourage buying holiday gifts earlier could also lessen the importance of Cyber Monday, the first Monday after Thanksgiving.","news_type":1},"isVote":1,"tweetType":1,"viewCount":732,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"defaultTab":"following","isTTM":false}